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Purpose: To describe the clinical findings of a patient with an early onset retinal dystrophy and a novel mutation in
OTX2, and to compare these findings with previously reported cases.
Methods: Using direct sequencing, we screened 142 patients, who had either Leber congenital amaurosis (LCA) or early
onset retinal dystrophy (EORD), for mutations in OTX2. All patients received a detailed ophthalmic examination including
electroretinography and retinal imaging.
Results: Only one mutation in OTX2 was identified. A novel heterozygous p.S138X stop mutation was identified in a
seven-year-old male who had an infantile onset retinal dystrophy. The mutation was not present in either parent or in 181
blood donor samples. There was a history of failure to thrive in infancy, poor feeding, and growth hormone deficiency.
Poor vision and nyctalopia was present from the first year. Funduscopy revealed a hyperpigmented peripapillary ring with
a fine granular pigmentation of the RPE throughout the fundus. The scotopic bright flash ERG a-wave was subnormal
and  the  waveform  electronegative,  in  keeping  with  dysfunction  both  at  the  level  of  the  photoreceptor  and  post-
phototransduction. Visual function has been stable to date.
Conclusions: Mutations in OTX2 have been reported in association with major developmental malformations of the eye,
with retinal dystrophies such as LCA, and with pituitary dysfunction and seizure activity in some cases. This case adds
further support for a role of OTX2 both in retinal development and pituitary function, and highlights a novel retinal
dystrophy phenotype seen in association with mutations in OTX2.
The  orthodenticle  protein  homolog  2  (OTX2)  is  a
homeobox  gene  that  plays  a  critical  role  in  retinal
photoreceptor  development.  The  gene,  on  chromosome
14q23.1, is organized into five exons, only three of which are
translated.  It  contains  a  highly  conserved  homeodomain.
OTX2  is  expressed  during  development  in  the
neuroepithelium  of  most  of  the  forebrain  and  midbrain,
including  the  eye  domain  [1].  Complete  elimination  of
OTX2 function in mice by gene targeting results in the absence
of the forebrain and embryonic lethality [2,3]. While Otx2 null
embryos  display  a  severe  cranial  phenotype,  lacking  the
anterior neuroectoderm, and with abnormalities in body plan
[2,3],  heterozygous  deletion  of  Otx2  leads  to  a  variable
phenotype that is dependent on genetic background. Otx2+/−
mice  can  be  normal,  have  developmental  eye  anomalies
including  anterior  segment  malformations,  severe  eye
abnormalities such as microphthalmia or anophthalmia, or
head abnormalities [2,4]. In early development Otx2, specifies
the  anterior  neuroectoderm  during  gastrulation  [2]  and  is
expressed  throughout  the  forebrain  and  midbrain  in  the
developing embryo [1]. Once eye development is specified,
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expression of Otx2 narrows. It is required for the development
of  the  presumptive  retinal  pigment  epithelium  (RPE)  [5],
where  it  has  a  continuing  maintenance  role  throughout
adulthood [6]. Analysis of Otx2−/− mice has shown that it is
essential for specification of the RPE; loss of OTX2 function
results in the outer layer of the optic cup developing into
ectopic neural retina [7]. However, OTX2 is also required for
the development and maintenance of the neural retina. Otx2
protein is found in bipolar and in ganglion cells [6,8,9], while
in the outer nuclear layer it regulates the expression of the
closely related Crx gene that controls the expression of a suite
of photoreceptor function genes, including opsins. Otx2 and
Crx can also bind to common DNA-binding sequences [10].
Ablation of OTX2 in retinal progenitor cells has been shown
to affect RPE development and leads to a significant decrease
in rod photoreceptors and bipolar cells, suggesting that OTX2
is also involved in retinal bipolar cell development [8]. It has
recently been demonstrated that OTX2 protein is transported
from the retina to the visual cortex in the developing rat, and
appears to modify postnatal synaptic plasticity [9].
OTX2 mutations in humans have been associated with a
range  of  ophthalmological  phenotypes  including
anophthalmia, microphthalmia, developmental anomalies of
the optic nerve and chiasm, and Leber congenital amaurosis
(LCA). As OTX2 plays a key role in retinal development, and
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2442a mutation in OTX2 has been reported in association with an
infantile onset retinal dystrophy [11], we screened a large
panel of patients with LCA and other forms of childhood onset
retinal dystrophy for mutations in this gene.
METHODS
A panel of DNA from 142 patients with LCA and severe
childhood  onset  retinal  dystrophy  were  recruited  at
Moorfields Eye Hospital and The Hospital for Children, Great
Ormond Street, London, as part of an ongoing molecular
genetic study of childhood retinal dystrophies. The research
has local research ethics committee approval and conformed
to the tenets of the Declaration of Helsinki. A full clinical
history was taken and examination performed in all subjects.
In older children and adults this included, where possible, best
corrected logMAR visual acuity and color vision (Hardy Rand
Rittler,  Richmond  Products,  Albuquerque,  NM);  slit-lamp
biomicroscopy or indirect ophthalmoscopy; Goldmann visual
fields;  autorefraction  (Luneau  L62–3D
autorefractokeratometer - LUNEAU Chartres, France), axial
length measurement, and auto-keratometry (IOL Master, Carl
Zeiss Meditec, Dublin, CA); optical coherence tomography
(Stratus OCT™ - software version 3; Carl Zeiss Meditec,
Inc.); fundus photography (TRC-50IX with IMAGEnet 2000
system software–TOPCON Corporation, Japan), and fundus
autofluorescence  (Heidelberg  Retinal  Angiograph-II,
Heidelberg Engineering, Heidelberg, Germany). All patients
had electroretinography performed either at our institutions or
at the referring hospital. Most patients had tests performed at
diagnosis which, in the older patients, predated the ISCEV
standards. Patients seen more recently, or in whom we wished
to confirm the diagnosis, had electroretinography conducted
in accordance with current International Society for Clinical
Electrophysiology of Vision standards using gold foil or DTL
electrodes [12,13]. ERG testing in infants and young children
was  performed  using  skin  electrodes  in  accordance  with
previously published protocols [14,15].
DNA was extracted from whole blood obtained from each
affected individual and immediate family members using the
Nucleon  BACC-2  kit  (GE  Healthcare)  performed  as  per
manufacturer’s instructions. DNA samples from all patients
were sent to Asper Ophthalmics (Tartu, Estonia) for analysis
using the LCA chip [16]. This is a microarray which contained
(at the time of the study) 344 disease associated SNPs and
several  common  variant  polymorphisms  in  six  LCA
associated genes and 2 early onset genes (GUCY2D, CRX,
RPE65,  CRB1,  RPGRIP1,  AIPL1,  LRAT,  and  MERTK).
Genorama genotyping software (Asper Ophthalmics Ltd) can
subsequently produce a bidirectional allele call at each SNP
being interrogated. The panel subsequently underwent direct
sequencing of PCR products [11] performed using an ABI
3130 36 cm capillary sequencer (Applied Biosystems, Inc.,
Foster City, CA). 181 control DNA samples isolated from
anonymous Aberdeen-based blood donors were screened for
DNA  mismatches  using  the  Idaho  Technology  Inc.  Light
Scanner  (Salt  Lake  City,  UT).  Fragments  revealing  a
nucleotide mismatch were fully sequenced to identify the
mutations.
RESULTS
A de novo heterozygous c.413C>G p.S138X stop mutation
was identified in a seven-year-old male (Figure 1; Pt 13424)
who was negative for all variants assayed by the LCA chip.
The mutation was not present in either parent. This mutation
was not detected in 181 controls. Known polymorphic single
nucleotide polymorphisms (SNPs), were observed at similar
frequencies in the disease cohort and the blood donor controls,
indicating that the ethnic background of the patient cohort and
the controls was comparable.
Figure  1.  Direct  sequencing.  At  the
position  indicated  by  the  black
arrowhead,  the  heterozygous  C>G
change is revealed in the DNA sequence
trace for patient NH13424. Below this
the wild type trace for normal control
subject DIFIG is shown.
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2443The patient had a history of failure to thrive from birth
and multiple investigations of the possible cause including
investigations for Batten disease, Williams syndrome, and
Russell-Silver dwarfism, all of which were negative. At 9
months  old,  required  nasogastric  feeding  for  6  months
following a history of failure to thrive. He has always been on
the lowest percentiles for stature. Growth hormone deficiency
was suggested indirectly via low levels of IGF1 and IGFBP3.
An MRI scan was reported as normal. His parents noted poor
vision and nyctalopia during his first year of life. There was
no family history of eye disease. One younger sibling who has
no visual problems was unavailable for further investigation.
Ophthalmic  examination  when  he  was  six  years  old
disclosed  a  small  angle  alternating  esotropia  with  mild
torsional  nystagmus.  Visual  acuities  were  0.4  and  0.5
logMAR in his right and left eyes, respectively. Cycloplegic
retinoscopy revealed a refractive error of 0.00 diopter sphere/
+3.00 diopter cylinder at 180 degrees in the right eye, and
+3.00 diopter sphere /+2.50 diopter cylinder at 180 degrees in
the left. He had normal color vision, according to Hardy Rand
Rittler;  he  had  normal  pupil  reactions  and  clear  lenses.
Funduscopy  revealed  a  hyperpigmented  area  of  retina
surrounding the optic disc with a fine granular pigmentation
of the RPE throughout the fundus (Figure 2). There was no
vascular attenuation.
ERGs  were  performed  according  to  international
standards  [13].  The  dark-adapted  bright  flash  ERG  was
markedly electronegative with additional a-wave reduction.
Light-adapted flicker ERGs were delayed and subnormal and
the single flash cone ERG was subnormal with a reduced b:a
ratio  (Figure  3).  The  profoundly  negative  ERG  suggests
dysfunction that is both marked and at a level that is post-
phototransduction, usually post-receptoral. The a-wave was
subnormal  but  not  delayed,  indicating  additional  loss  of
photoreceptor function. The ON-OFF and S-cone ERGs [17,
18]  suggesting  greater  ON-  than  OFF-  bipolar  pathway
involvement. The pattern ERG P50 component was reduced
bilaterally, which is consistent with macular involvement.
(Figure 3)
DISCUSSION
This study provides evidence of a novel mutation in OTX2
associated with early onset retinal dystrophy and pituitary
insufficiency. This mutation is predicted to lead a truncated
protein. Chatelain et al. [19] observed that OTX2 truncation
at residues 106 and 161, flanking the site of the predicted
termination, described here, leads to loss of transactivation
function. This strongly suggests that the mutation identified
in our patient is also likely to cause haploinsufficiency.
Clinical  studies  have  demonstrated  that  mutations  in
OTX2 are associated with a wide range of ocular phenotypes
(Table 1) [7,11,20–22]. Experimentally, the role of OTX2 in
regional specification of the eye, particularly the RPE, has
long been established from expression studies in normal and
mutant animal models [1,4,23–26]. Subsequent studies have
also demonstrated the role of OTX2 in the development of both
the retinal photoreceptors and bipolar cells [25,27]. It has been
hypothesized that OTX2 is involved in retinal photoreceptor
cell fate but not in bipolar cell fate in early development, while
it  is  involved  in  the  terminal  differentiation  of  both
Figure 2. Fundus photography. Images are right and left eye color fundus photograph composites of patient NH13424 performed using
TOPCON retinal camera at 2.45x magnification at 35 degrees. Composite images were created using Adobe Photoshop. Image cropping and
reflections are observed secondary to poor pupil dilatation. The images show significant and abnormal peripapillary hyperpigmentation with
fine granular pigmentation at the level of the retinal pigment epithelium (RPE).
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2444photoreceptors  and  bipolar  cells  late  in  development  in
cooperation with CRX [8]. Pituitary dysfunction has been
described  in  two  patients  with  heterozygous  14q22–23
microdeletions involving OTX2 [28,29]. Recently, the role of
OTX2 in pituitary development has been further delineated
with three case reports of OTX2 mutations associated with
pituitary hormone deficiency (CPHD) [21,22]. A further case
of  anophthalmia  associated  with  an  OTX2  mutation  was
reported  to  have  isolated  growth  hormone  deficiency  and
short stature [7]. In the latter publication a requirement for
OTX2 binding was postulated at a site previously shown to
lie in the promoter of HESX1 [30].
Figure 3. Electrophysiology. Full-field
ERGs and pattern ERGs from the right
(row 1) and left eye (row 2) of the patient
and  normal  examples  (row  3)  for
comparison.  Full-field  ERGs  were
performed using corneal electrodes in
August 2007; pattern ERGs had been
recorded  to  a  30  degree  field
checkerboard stimulus using periorbital
surface  electrodes  two  years  earlier.
Dark-adapted ERGs are shown for flash
intensities  of  0.01  and  11.5  cd.s.m−2;
light-adapted ERGs for a flash intensity
of 3.0 cd.s.m−2 at 30 Hz (flicker) and at
2 Hz.. ON-OFF ERGs used an orange
stimulus (560 cd.m−2, duration 200 ms)
superimposed  on  a  green  background
(150 cd.m−2). S-cone ERGs used a blue
stimulus  (445  nm,  80  cd.m−2)  on  an
orange background (620 nm, 560 cd.m
−2). Eye movement artifacts are replaced
by broken lines for clarity. S-cone ERGs
were unavailable for the right eye.
TABLE 1. PREVIOUSLY PUBLISHED MUTATIONS IN OTX2 WITH ASSOCIATED PHENOTYPES.
Nucleotide Protein Phenotype Reference
c.674A>G p.Asn225Ser CPHD [22]
c.674A>G p.Asn225Ser CPHD [22]
whole gene deletion whole gene deletion Extreme microphthalmia [20]
whole gene deletion whole gene deletion Anophthalmia [20]
c.93C>G p.Tyr31X Microphthalmia [20]
c.106dupC p.Arg36ProfsX52 Microphthalmia OD/ normal OS [20]
c.106dupC p.Arg36ProfsX52 Anophthalmia OD/ Coloboma OS [20]
c.289C>T p.Gln97X Extreme microphthalmia [20]
c.289C>T p.Gln97X Inferior iris coloboma OD/ retinal coloboma OS [20]
c.373_374delAG p.Gly126TrpfsX11 Anophthalmia [20]
c.404_405dupCT p.Ser136LeufsX43 Anophthalmia and CPHD [21]
c.402dupC p.Ser135LeufsX2 Anophthalmia, GH deficiency; cleft palate [7]
c.463_464dupGC p.Ser156LeufsX23 bilateral anophthalmia; developmental delay [11]
c.265C>G p.Arg89Gly bilateral microphthalmia [11]
c.81delC p.Ser28ProfsX23 bilateral severe microphthalmia [11]
c.537T>A p.Tyr179X severe microphthalmia and colobomata, developmental delay seizures [11]
c.537T>A p.Tyr179X bilateral mild microphthalmia, retinal dystrophy originally described as LCA [11]
c.117_118delCC p.Arg40GlyfsX47 bilateral anophthalmia [11]
c.295C>T p.Gln99X bilateral anopthalmia [11]
c.397C>A p.Pro133Thr bilateral microphthalmia [11]
c.400C>G p.Pro134Ala anophthalmia OS/ OD normal [11]
Mutations in OTX2. a summary of the published cases. Table lists previously published mutations in OTX2 with associated
phenotypes. The nucleotide and protein nomenclature used conforms to current standards and may differ from the notation used
in the original publications (LOVD). Abbreviations: CPHD represents combined pituitary hormone deficiency; OD represents
right eye; OS represents left eye; GH represents growth hormone.
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2445The phenotypic spectrum described in this case report is
consistent with the assigned multiple roles of OTX2 in the
development and function of both RPE and neural retinal, as
well as in the pituitary. Mutations in OTX2 are a rare cause of
infantile  onset  retinal  dystrophies  and  the  finding  of  an
electronegative  ERG  with  additional  a-wave  reduction
suggests  that  there  is  dysfunction  at  the  level  of  the
photoreceptor  and  also  post-phototransduction,  likely  to
involve  both  ON-  and  OFF-  bipolar  cells.  Funduscopy
revealed a fine granular pigmentation of the RPE. In addition,
an unusual hyperpigmented juxtapapillary ring, not normally
seen in retinal dystrophies, was observed. The history of early
failure to thrive and subsequent short stature with low implied
growth hormone levels adds further support for a role for
OTX2 in pituitary function.
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